Benchmark Begins Coverage on XOMA (NASDAQ:XOMA)
Benchmark started coverage on shares of XOMA (NASDAQ:XOMA – Free Report) in a report published on Thursday morning, Marketbeat.com reports. The brokerage issued a buy rating and a $35.00 price target on the biotechnology company’s stock. XOMA has been the topic of several other reports. StockNews.com upgraded XOMA from a “sell” rating to a “hold” […]
Benchmark started coverage on shares of XOMA (NASDAQ:XOMA – Free Report) in a report published on Thursday morning, Marketbeat.com reports. The brokerage issued a buy rating and a $35.00 price target on the biotechnology company’s stock. XOMA has been the topic of several other reports. StockNews.com upgraded XOMA from a “sell” rating to a “hold” […]
